Brainstorm Cell Therapeutics | BCLI - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Biogen USD 146.7M 200K 2025-09
Brainstorm Cell Therapeutics USD 11.04M 2K 2025-12
Cipla INR 807.78M 17K 2026-03
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1.02M 2025-12
CSL USD 482.13M 93.87M 2025-12
Cytokinetics USD 124.43M 2.17M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-03
Grifols EUR 680.58M 846.11K 2025-12
Halozyme Therapeutics USD 118.52M 741K 2026-03
Mesoblast USD 1.29B 8.58M 2025-12